Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Celldex Therapeutics, Inc. | EXECUTIVE VP & CSO | Incentive Stock Option (right to buy) | 93K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLDX | Celldex Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | EXECUTIVE VP & CSO |
CLDX | Celldex Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | EXECUTIVE VP & CSO |
CLDX | Celldex Therapeutics, Inc. | Dec 7, 2022 | 3 | -$576K | 4 | Dec 9, 2022 | EXECUTIVE VP & CSO |
CLDX | Celldex Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | EXECUTIVE VP & CSO |
CLDX | Celldex Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Executive VP & CSO |